Navigation Links
SAGE and Hindawi announce landmark open access agreement
Date:11/20/2007

n ideal partner for SAGE, being able to offer a highly effective publishing system that will allow us to focus on our longstanding reputation for high quality marketing and editorial expertise, while offering a viable option for disseminating open, unrestricted access to research.

We are delighted to be working with SAGE on this joint initiative, said Ahmed Hindawi, CEO of Hindawi Publishing Corporation. Hindawi currently has a very successful Open Access journal collection, which is quite solid both academically and financially, and SAGEs strong market presence and expertise will enable us to further expand our Open Access offerings to the scientific communities we serve.


'/>"/>

Contact: Mithu Mukherjee
mithu.mukherjee@sagepub.co.uk
SAGE Publications
Source:Eurekalert

Page: 1 2

Related biology news :

1. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
2. LaserCard Corporation Announces Expansion of Middle East Project
3. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
4. Saflink and IdentiPHI Announce Merger Agreement
5. Balzan Foundation announces 2007 winners
6. The American Society of Plant Biologists announces 2007 awards
7. ASPB announces Summer Undergraduate Research Fellowship 2007 recipients
8. Saflink and IdentiPHI Announce Merger Agreement
9. NIST announces 56 new awards for innovative technology research and development
10. Titanium Group Announces Contract With Haitong Securities
11. Costa Rica, US announce historic debt-for-nature swap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)... H. Jones, deputy executive director of the Intern...rgy Outlook 2008" Dec. 9 at Rice University,s Bake...ess such questions as: Is the world facing a suppl...nt? What type of post-Kyoto policy framework might...evels, and what impact might such a policy framewo...
(Date:12/3/2008)...what,s number one at the box office this week. The...kings of the body, filmed by scientists using grou... Australia, scientists at Sydney,s Centenary Insti...by a parasite and followed the infection as it beg...Wolfgang Weninger, head of the Immune Imaging prog...
(Date:12/3/2008)...AND, Ore. December 3, 2008. The first 5-year fores... lands is now available to the public: Oregon,s Fo...ory and Analysis Report. , Here are some key fin... about 30 million acres; about half of Oregon,s to...is being converted to other uses particularly near...
(Date:12/3/2008)...A, Mo. "FORE"...Though they may not help improve ...nge the way golfers think about the local country ...y of Missouri study. , "There are more than 17,0...ately 70 percent of that land is not used for play...iology in the MU College of Arts and Science. "The...
Breaking Biology News(10 mins):'World Energy Outlook' to be presented at Rice University Dec. 9 2Scientists film inner workings of the immune system 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Golf course: Playing fields, wildlife sanctuaries or both 2Poniard Announces Positive First Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory 2252 1Poniard Announces Positive First Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory 2252 2Poniard Announces Positive First Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory 2252 3Poniard Announces Positive First Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory 2252 4Data Confirm Avastin 28R 29 Helps Patients With Metastatic Colorectal Cancer Live Even Longer 2250 1Data Confirm Avastin 28R 29 Helps Patients With Metastatic Colorectal Cancer Live Even Longer 2250 2Data Confirm Avastin 28R 29 Helps Patients With Metastatic Colorectal Cancer Live Even Longer 2250 3New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 1New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 2New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 3New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 4New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 5New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2248 6NYP Weill Cornell physician scientists present latest cancer findings at ASCO meeting 20747 1NYP Weill Cornell physician scientists present latest cancer findings at ASCO meeting 20747 2NYP Weill Cornell physician scientists present latest cancer findings at ASCO meeting 20747 3NYP Weill Cornell physician scientists present latest cancer findings at ASCO meeting 20747 4
...chronic and progressive lung disorder from which m...he disease is characterized by the insidious onset... , Now, Selman and coworkers present in an artic...oS ONE on Wednesday 30th May, strong evidence indi...uration of symptoms before diagnosis and display a...
...rshed decision to propose listing the polar bear a...he Wildlife Conservation Society (WCS) is launchin...rrestrial predator, not by following the bears the... drastically shrink as a result of global warming....WCS will use both current and historical satellite...
...symptoms in people with Parkinson,s disease and ot...t the electrical signals of their diseased brains....ich have been approved by the Food and Drug Admini...,000 Americans, the mechanisms by which deep brain...ll understood. , Biomedical engineers at Duke U...
... Institutes of Health (NIH), researchers from Rens...ics-based virtual model that can simulate a patien...on with existing 3-D models, adding the fourth dim...uracy and effectiveness of radiation treatment for...or of nuclear and biomedical engineering, and Suvr...
Other Biology News:Extra-aggressive form of idiopathic pulmonary fibrosis identified 2Want to save polar bears? Follow the ice 2Want to save polar bears? Follow the ice 3How brain pacemakers erase diseased messages 2How brain pacemakers erase diseased messages 3'Virtual Patient' to simulate real-time organ motions for radiation therapy 2
(Date:12/4/2008)...ire-FirstCall/ -- NeoStem, Inc.,(NYSE Alternext U...ction,processing and long-term storage of adult ...ed that it has reached a major milestone in its cu... ever collection center for collection of,adult s... need in New York,City and has chosen Bruce Yaffe...
(Date:12/4/2008)... MedImmune today announced that,i...ts with chronic asthma to,determine the safety of...ibody,(MAb) that targets the interleukin-5 recept...ing the IL-5R pathway may lead to a targeted appro... continued study of this antibody. , "Asthm...
(Date:12/4/2008)...swire/ -- Azur Pharma Limited ("Azur") today,anno...ent with BioSante,Pharmaceuticals, Inc ("BioSante...strin(TM). Elestrin is a fast drying gel formulati...ent of moderate to severe vasomotor symptoms,asso...e U.S. Food and Drug,Administration ("FDA") in De...
(Date:12/4/2008)...New Trade Name Onrigin(TM) for Laromustine , ,.../ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Boa...d to events in connection with the 50th American S... Center in San Francisco from December 6-9, 2008. ... The Company announced that it would present sur...
Breaking Biology Technology:NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4
.... - GE Healthcare,s efforts to create an early ...Electric Co.,s pending acquisition of Abbott Lab... diagnostics business units, according to GE execu...entered into a definitive agreement for GE, the pa...aboratory diagnostics business units for $8.13 bil...
...s. - The Medical College of Wisconsin , in respo...ed research, has been awarded a five-year, $8.1 mi...diagnostic device to test for avian flu and the ma...ant, which was awarded by the National Institutes...iseases , will be used to develop a device that wo...
...os is founder and CEO of the Delphi Group, a Bosto...and strategy, and director of Perot Systems, Innov...is February to speak at the Fusion 2007 CEO-CIO S...hts into the ways business and information technol...fective. , , WTN: What,s the ideal situation for ...
... - With its first accelerator building fully comm...break ground this spring on a new, 50,000 square f...h will be built next to Third Wave Technologies, w...he MGE Innovation Center, the park,s business incu...ll range in size from 2,500 to 5,000 square feet, ...
Other Biology Technology:GE acquisition may boost "early" healthcare strategy 2Medical College lands $8.1M grant to detect bird flu, bioterror agents 2Innovation expert speaks on the business-IT balancing act 2Innovation expert speaks on the business-IT balancing act 3Innovation expert speaks on the business-IT balancing act 4Innovation expert speaks on the business-IT balancing act 5Research park to add accelerator suites 2
...er combines top performance with exquisite design....unparalleled temperature uniformity. The instrumen...g in a spreadsheet or alternatively in a graphical... push of a button and swings in a defined end posi...
...d to be a solid, heavy-duty durable orbital shaker...nd vortexing in nature. The VSOS-4 Orbital Shak...orm orbital shaking motion (19mm circular) for a w...tissue culture, hybridization, staining and destai...
Preparation TW--Compatibility: no end cap seals -Hybridization Tube for Hybrigene -Comp Dim: 240 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-15
...are designed for the rapid purification of linear ...d is excised from an,agarose gel and loaded into t...lumn are a series of membranes and filters that ho...to selectively pass through the column into a coll...
Biology Products: